A Randomized, Controlled, Open Label, Multicentre Clinical Trial to explore Safety and Efficacy of Hyperbaric Oxygen for preventingICU admission, Morbidity and Mortality in Adult Patients With COVID-19 : A Randomized, Controlled, Open Label, Multicentre Clinical Trial to explore Safety and Efficacy of Hyperbaric Oxygen for preventingICU admission, Morbidity and Mortality in Adult Patients With COVID-19 - COVID-19-HBO

Medienart:

Klinische Studie

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

WHO International Clinical Trials Registry Platform - (2022) vom: 14. Nov. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: SARS-CoV-2
Phase: Phase 2
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 11-05-2020, Last updated: 2022-11-24

ICTRP ID:

DRKS00021626
2020-001349-37
NCT04327505
5.1-2020-36673

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO006472656